Literature DB >> 4686402

Determination of dantrolene in biological specimens containing drug-related metabolites.

R D Hollifield, J D Conklin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4686402     DOI: 10.1002/jps.2600620219

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  8 in total

Review 1.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 2.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

Review 3.  Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

4.  The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration.

Authors:  W J Meyler; H Bakker; J J Kok; S Agoston; H Wesseling
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

5.  Relationship between plasma concentration and effect of dantrolene sodium in man.

Authors:  W J Meyler; H W Mols-Thürkow; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

Review 6.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

7.  Muscle relaxant properties of the identified metabolites of dantrolene.

Authors:  K O Ellis; F L Wessels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

8.  Green spectrofluorimetric assay of dantrolene sodium via reduction method: application to content uniformity testing.

Authors:  Nora A Abdalah; Mona E Fathy; Manar M Tolba; Amina M El-Brashy; Fawzia A Ibrahim
Journal:  R Soc Open Sci       Date:  2021-07-14       Impact factor: 2.963

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.